Type 2 & other diabetes

Cardiometabolic multimorbidity prevalence and mortality risks in Chinese old-old population: real-world evidence from continuing care retirement community

Diabetes Res Clin PractPublished Retrospective cohort study

Authors' conclusion

Among Chinese old-old population, hypertension was the most prevalent cardiometabolic condition, with hypertension-diabetes being the most prevalent CMM pattern. Uncomplicated hypertension or diabetes without organ damage was associated with limited increase in mortality risk when well-managed, whereas HF as the greatest risk factor warrant more proactive follow-up interventions.

Study context

Population
Very elderly Chinese in Taikang Community (continuing care retirement community); median age 83.3 years
Participants
20,360 participants
Outcome
Prevalence of cardiometabolic diseases (hypertension, DM, CHD, stroke, HF) and CMM patterns
Methodological detailsreal-world, continuing care retirement community
  • Real-world
  • Continuing care retirement community

Main finding

As reported in the abstract

Hypertension prevalence (most prevalent cardiometabolic condition)

78.8%

Overall cardiometabolic multimorbidity (CMM) prevalence

51.8%

Hypertension-DM (most prevalent CMM pattern)

16.5%

Observational data: associations, not effects.

Further findings

Disease management achievement rates (subgroup with follow-up)

Hypertension
54.6%
DM
70.0%
CHD
18.1%

Mortality risk (weighted logistic regression)

Independent mortality risk in descending order: Heart failure (HF), CHD, stroke, DM, hypertension
DM as comorbidity of hypertension had minimal influence on mortality risk

Original publication

Cardiometabolic multimorbidity prevalence and mortality risks in Chinese old-old population: real-world evidence from continuing care retirement community. Diabetes Res Clin Pract. Published 17 February 2026. doi:10.1016/j.diabres.2026.113164

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.